DNMT1 and myelodysplastic syndrome: Similarly, DNA methyltransferase (DNMT) inhibitors like Azacitidine and Decitabine have shown survival benefits in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS); yet, hematological toxicities and limited efficacy in fast proliferating AML cells remain challenges189,190.